These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11365415)

  • 1. Experts clarify issues raised by combination therapy.
    AIDS Alert; 1998 May; 13(5):suppl 1-2. PubMed ID: 11365415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do you handle those borderline cases?
    AIDS Alert; 1998 May; 13(5):55-8. PubMed ID: 11365413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panels to develop standards for antiviral therapy, viral-load testing.
    AIDS Alert; 1997 Feb; 12(2):13-5. PubMed ID: 11364029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term strategies: should some patients wait to start protease inhibitors? Interview with Keith Henry, M.D. Interview by John S. James.
    Henry K
    AIDS Treat News; 1997 Oct; (No 281):1, 3-6. PubMed ID: 11364791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chat with HIV specialists: the Geneva report.
    Newsline People AIDS Coalit N Y; 1998 Sep; ():12-7. PubMed ID: 11367483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone, adherence and protease inhibitors.
    Treat Rev; 1997 Aug; (No 25):2-3. PubMed ID: 11364614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New TB therapy works for HIV-positive patients.
    AIDS Alert; 1998 May; 13(5):58-9. PubMed ID: 11365414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS practice issues today: interview with Paul Bellman, M.D. Interview by John S. James.
    Bellman P
    AIDS Treat News; 2000 Apr; (No 340):1-6. PubMed ID: 11367198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence and double therapies: an interview with Charles Farthing, M.D. Interview by Marcelo Marer.
    Farthing C
    Body Posit; 1998; 11(4-5):28-33. PubMed ID: 11365254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicians explore ways to ensure compliance.
    AIDS Alert; 1997 Feb; 12(2):17-8. PubMed ID: 11364031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double jeopardy: the hazards of drug-drug interactions.
    Flexner C
    Res Initiat Treat Action; 1998 Dec; 4(7):3-8. PubMed ID: 11366084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitor plasma concentrations in HIV antiretroviral therapy.
    Justesen US
    Dan Med Bull; 2008 Nov; 55(4):165-85. PubMed ID: 19232158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.
    Tavassoli N; Bagheri H; Sommet A; Delpierre C; Marion-Latard F; Massip P; Aquilina C; Bonnet E; Obadia M; Labau E; Montastruc JL; Bernard J
    Pharmacotherapy; 2006 Feb; 26(2):154-61. PubMed ID: 16466321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antiretroviral tactics: transitions or mere trends? An interview with Joep Lange,MD,PhD. Interview by Mark Mascolini.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1999 Jul; 5(7):25-9. PubMed ID: 11367133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health officials argue that generalists can treat HIV.
    AIDS Alert; 1997 Sep; 12(9):104-5. PubMed ID: 11364585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.